Date | Insider | Price | Amount |
---|---|---|---|
7-30-2012 Insider Buy |
Thomas Watkins Chief Executive Officer |
$9.67 CAGR » |
$42,499.08 4,394 shares |
8-2-2012 Insider Buy |
Plc Glaxosmithkline Director and >10% Owner |
$14.25 CAGR » |
$973,743,839.25 68,332,901 shares |
8-1-2012 Insider Buy |
Plc Glaxosmithkline Director and >10% Owner |
$14.25 CAGR » |
$95,801,738.25 6,722,929 shares |
8-5-2011 Insider Buy |
Ngoc Tuan HA Director |
$16.00 CAGR » |
$160,000.00 10,000 shares |
8-5-2011 Insider Buy |
George J. Morrow Director |
$15.79 CAGR » |
$157,900.00 10,000 shares |
8-4-2011 Insider Buy |
Colin Goddard Director |
$16.17 CAGR » |
$48,510.00 3,000 shares |
3-22-2011 Insider Buy |
Colin Goddard Director |
$27.41 CAGR » |
$74,727.84 2,726 shares |
3-18-2011 Insider Buy |
Gregory Norden Director |
$27.12 CAGR » |
$67,797.50 2,500 shares |
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 07/31/2012 | |
End date: | 08/03/2012 | |
Start price/share: | $14.24 | |
End price/share: | $14.24 | |
Dividends collected/share: | $0.00 | |
Total return: | 0.00% | |
Annualized Gain: | 0.00% | |
Starting investment: | $10,000.00 | |
Ending investment: | $10,000.00 | |
Years: | 0.01 |
HGSI Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent HGSI insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Free HGSI Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the HGSI Insider Buying occurred are:
MHP Insider Buying |